Bevyxxa Alternatives Compared
Bevyxxa | Eliquis | Fragmin |
|
---|
Bevyxxa (betrixaban) | Eliquis (apixaban) | Fragmin (dalteparin) |
|
|||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Venous Thromboembolism. Bevyxxa may also be used for purposes not listed in this medication guide. |
Prescription only
Eliquis reduces the clotting ability of the blood and is used in the treatment and prevention of several medical conditions associated with blood clots. It does not require monitoring, and an... View more |
Prescription only
Prescribed for Deep Vein Thrombosis Prophylaxis after Orthopedic Surgery, Deep Vein Thrombosis Prophylaxis after Hip Replacement Surgery, Deep Vein Thrombosis Prophylaxis after Abdominal Surgery... View more |
Related suggestions Venous Thromboembolism
|
|||||||||||||||
More about Bevyxxa (betrixaban) | More about Eliquis (apixaban) | More about Fragmin (dalteparin) | ||||||||||||||||
Ratings & Reviews | ||||||||||||||||||
Be the first to share your experience with this drug. |
Eliquis has an average rating of 5.0 out of 10 from a total of 224 ratings on Drugs.com. 35% of reviewers reported a positive effect, while 42% reported a negative effect. |
Fragmin has an average rating of 6.0 out of 10 from a total of 5 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 33% reported a negative effect. |
||||||||||||||||
Drug Class | ||||||||||||||||||
Side Effects | ||||||||||||||||||
See also: Bevyxxa side effects in more detail. |
See also: Eliquis side effects in more detail. |
See also: Fragmin side effects in more detail. |
||||||||||||||||
Generic Availability | ||||||||||||||||||
N/A |
||||||||||||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Eliquis prices |
View all Fragmin prices |
||||||||||||||||
Dosage Form(s) Available | ||||||||||||||||||
|
|
|
||||||||||||||||
Brand Names | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||
27 hours |
12 hours |
5 hours |
||||||||||||||||
CSA Schedule ** View glossary of terms | ||||||||||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
Pregnancy Category | ||||||||||||||||||
Summary unavailable. See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
Category B
No proven risk in humans
See the full pregnancy warnings document. |
||||||||||||||||
Drug Interactions | ||||||||||||||||||
A total of 277 drugs are known to interact with Bevyxxa:
|
A total of 374 drugs are known to interact with Eliquis:
|
A total of 192 drugs are known to interact with Fragmin:
|
||||||||||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||
Disease Interactions | ||||||||||||||||||
First Approval Date | ||||||||||||||||||
June 23, 2017 |
December 28, 2012 |
December 22, 1994 |
||||||||||||||||
WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||
N/A |
N/A |
N/A |
||||||||||||||||
More Information | ||||||||||||||||||
Patient resources | ||||||||||||||||||
Professional Resources | ||||||||||||||||||
Related Treatment Guide | ||||||||||||||||||
|
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.